NCT01251861 2026-03-18
Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
23 trialsNCT03055013 2026-03-17
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT06733350 2026-02-09
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Phase 4 Suspended
NCT02914873 2026-01-20
PCASTT
Uppsala University
Phase NA Active not recruiting
NCT06378866 2025-12-26
DIVINE
Mayo Clinic
Phase 2 Recruiting
NCT04216290 2025-11-12
A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04519879 2025-10-29
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
City of Hope Medical Center
Phase 2 Active not recruiting
NCT06200103 2025-09-11
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Mayo Clinic
Phase 2 Recruiting
NCT06537154 2025-07-30
NEO-BLAST
University of British Columbia
Phase 2/3 Recruiting
NCT07023432 2025-06-17
Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT06686381 2025-02-05
Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W
American University of Beirut Medical Center
Phase 2 Not yet recruiting
NCT02799745 2024-12-06
ENACT
Astellas Pharma Inc
Phase 2 Completed
NCT04029714 2024-02-23
Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment
Guy's and St Thomas' NHS Foundation Trust
Phase NA Active not recruiting
NCT05148728 2021-12-08
Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors
Vall Hebron Insitut Recerca
Phase NA Unknown
NCT01717677 2021-02-10
PREFERE
Association of Urologic Oncology (AUO)
Phase NA Terminated
NCT01928485 2020-10-22
Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT03804320 2020-02-11
Protocol Active Surveillance Small Renal Masses (SRMs)
IRCCS San Raffaele
Phase NA Recruiting
NCT01795365 2018-09-28
Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer
Centre Hospitalier Universitaire Vaudois
Phase NA Terminated
NCT02700724 2018-08-13
Observation Versus Immediate Surgery of Low Risk Bladder Cancer
Vanderbilt University Medical Center
Phase NA Terminated
NCT00002651 2017-04-17
SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
SWOG Cancer Research Network
Phase 3 Completed
NCT00376792 2013-08-26
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01193855 2013-08-26
Dutasteride in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00796874 2013-07-25
Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance
Roswell Park Cancer Institute
Phase NA Withdrawn